Mercator Medical S.A. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Mercator Medical S.A. cash flow conversion efficiency. Based on the latest financial reports, Mercator Medical S.A. (MRC) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł46.48 Million ≈ $12.79 Million USD) by net assets (zł890.05 Million ≈ $244.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mercator Medical S.A. (2012–2024)

Cash flow conversion efficiency of Mercator Medical S.A. from 2012 to 2024. This chart illustrates how Mercator Medical S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Mercator Medical S.A. stock price for real-time trading data and today's change.

Mercator Medical S.A. Cash Flow Conversion Ratio Explained

Mercator Medical S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mercator Medical S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mercator Medical S.A. ranked by their cash flow conversion efficiency. Also see Mercator Medical S.A. (MRC) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Melar Acquisition Corp. I Unit NASDAQ:MACIU	-0.001x
Kyeryong Const KO:013580	0.154x
Fasadgruppen Group AB ST:FG	0.124x
Currency Exchange International Corp TO:CXI	0.021x
Asian Hotels (North) Limited NSE:ASIANHOTNR	-0.675x
Platinum Group Metals Ltd TO:PTM	-0.006x
Ilshin Spinnin KO:003200	0.005x
Taisol Electronics Co Ltd TW:3338	0.002x

Annual Cash Flow Conversion Efficiency for Mercator Medical S.A. (2012–2024)

The table below shows the annual cash flow conversion efficiency of Mercator Medical S.A. from 2012 to 2024. Review MRC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł925.16 Million ≈ $254.62 Million	zł-72.06 Million ≈ $-19.83 Million	-0.078x	-77758.80%
2023-12-31	zł859.71 Million ≈ $236.60 Million	zł-86.00K ≈ $-23.67K	0.000x	-100.25%
2022-12-31	zł1.01 Billion ≈ $277.75 Million	zł40.79 Million ≈ $11.23 Million	0.040x	-90.80%
2021-12-31	zł1.15 Billion ≈ $315.18 Million	zł503.00 Million ≈ $138.43 Million	0.439x	-35.69%
2020-12-31	zł1.04 Billion ≈ $287.09 Million	zł712.47 Million ≈ $196.08 Million	0.683x	+138.32%
2019-12-31	zł134.46 Million ≈ $37.01 Million	zł38.53 Million ≈ $10.61 Million	0.287x	+565.01%
2018-12-31	zł133.29 Million ≈ $36.68 Million	zł-8.21 Million ≈ $-2.26 Million	-0.062x	-131.18%
2017-12-31	zł119.74 Million ≈ $32.95 Million	zł23.67 Million ≈ $6.51 Million	0.198x	+46.90%
2016-12-31	zł123.46 Million ≈ $33.98 Million	zł16.61 Million ≈ $4.57 Million	0.135x	+24.19%
2015-12-31	zł72.70 Million ≈ $20.01 Million	zł7.88 Million ≈ $2.17 Million	0.108x	-42.04%
2014-12-31	zł67.21 Million ≈ $18.50 Million	zł12.56 Million ≈ $3.46 Million	0.187x	+455.66%
2013-12-31	zł57.13 Million ≈ $15.72 Million	zł1.92 Million ≈ $528.96K	0.034x	-89.02%
2012-12-31	zł24.69 Million ≈ $6.80 Million	zł7.57 Million ≈ $2.08 Million	0.306x	--

About Mercator Medical S.A.

WAR:MRC Poland Medical Instruments & Supplies

Market Cap

$143.46 Million

zł521.25 Million PLN

Market Cap Rank

#17563 Global

#121 in Poland

Share Price

zł57.00

Change (1 day)

-1.38%

52-Week Range

zł37.45 - zł62.00

All Time High

zł680.00